Allergy medication in Japanese volunteers: treatment effect of single doses on nocturnal sleep architecture and next day residual effects

References

• Bousquet J, Cauwenberge van P, Khaltaev N; Aria workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(Suppl):147–334
   Google Scholar
• Simpson K, Jarvis B. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. Drugs 2000;59:301–21
   PubMed Web of Science ®Google Scholar
• Tharp MD. Chronic urticaria: pathophysiology and treatment approaches. J Allergy Clin Immunol 1996;98:S325–S330
   PubMed Web of Science ®Google Scholar
• Kay GG. The effects of antihistamines on cognition and performance. J Allergy Clin Immunol 2000;105:S622–S627
   PubMed Web of Science ®Google Scholar
• Llanes S, Grant A. Comparison of the potency of antihistamines. Dermatol Ther 2000;13:344–8
   Google Scholar
• Casale TB, Blaiss MS, Gelfand E, Gilmore T, et al. First do no harm: managing antihistamine impairment in patients with allergic rhinitis. J Allergy Clin Immunol 2003;111:S835–S842
   PubMed Web of Science ®Google Scholar
• Nicholson AN, Pascoe PA, Turner C, Ganellin CR, et al. Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene. Br J Pharmacol 1991;104:270–6
   PubMed Web of Science ®Google Scholar
• Clarke CH, Nicholson AN. Performance studies with antihistamines. Br J Clin Pharmacol 1978;6:31–3
   PubMed Web of Science ®Google Scholar
• Nicholson AN. Effect of the antihistamines, brompheniramine maleate and triprolidine hydrochloride, on performance in man. Br J Clin Pharmacol 1979;8:321–4
   Google Scholar
• Turner C, Hanford ADF, Nicholson AN. Sedation and memory: studies with a histamine H1-receptor antagonist. J Psychopharmacol 2006 [in press]
   Google Scholar
• Ter Laak AM, Donnè-Op den kelder GM, Bast A, Timmerman H. Is there a difference in the affinity of histamine H1-receptor antagonists for CNS and peripheral receptors? An in vitro study. Eur J Pharmacol 1993;232: 199–205
   Google Scholar
• Boyle J, Ridout F, Meadows R, Johnsen S, et al. Suppression of the histamine induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers. Curr Med Res Opin 2005;21:1495–503
   PubMed Web of Science ®Google Scholar
• Hindmarch I, Shamsi Z. Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects. Clin Exp Allergy 1999;29:133–42
   PubMed Web of Science ®Google Scholar
• Welch MJ, Meltzer FO, Simons FF. H1-antihistamines and the central nervous system. Clin Allergy Immunol 2002;17: 337–88
   Google Scholar
• Handley DA, Magnetti A, Higgins AJ. Therapeutic advantages of third generation antihistamines. Expert Opin Invest Drugs 1998;7:1045–54
   PubMedGoogle Scholar
• Conboy-Ellis K. Management of seasonal allergic rhinitis: comparative efficacy of the newer-generation prescription antihistamines. J Am Acad Nurse Pract 2005;17:295–301
   PubMedGoogle Scholar
• Bielory L, Lien KW, Bigelsen S. Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. Drugs 2005;65:215–28
   Google Scholar
• Prenner BM, Capano D, Harris AG. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders. Clin Ther 2000;22:760–9
   Google Scholar
• Hindmarch I, Shamsi Z, Stanley N. A double blind, placebo controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. Br J Clin Pharmacol 1999;48:200–6
   Google Scholar
• Hindmarch I, Shamsi Z, Kimber S. An evaluation of the effects of high dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers. Clin Exp Allergy 2002;32:133–9
   Google Scholar
• Nicholson AN, Stone BM, Turner C, Mills SL. Antihistamines and aircrew: usefulness of fexofenadine. Aviat Space Environ Med 2000;71:2–6
   PubMed Web of Science ®Google Scholar
• Hamelin BA, Bouayad A, Drolet B, Gravel A et al. In vitro characterisation of cytochrome P450 2D^ inhibition by classic histamine H1 receptor antagonists. Drug Metab Dispos 1998;26:536–9
   PubMed Web of Science ®Google Scholar
• Kubota T, Yamaura Y, Ohkawa N, Hara H, et al. Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes. J Clin Pharmacol 2000;50:31–4
   Web of Science ®Google Scholar
• Mason J, Reynolds R, Rao N. The systemic safety of fexofenadine HCl. Clin Exp Allergy 1999;29:163–70
   PubMedGoogle Scholar
• Tateishi T, Chida M, Ariyoshi N, Mizorogi Y, et al. Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population. Clin Pharmacol Ther 1999;65:570–5
   PubMed Web of Science ®Google Scholar
• Monti JM. Pharmacology of the histaminergic system. In Kales A, editor. Pharmacology of sleep. Berlin: Springer Verlag; 1995. p. 117–42
   Google Scholar
• Ridout F, Shamsi Z, Meadows R, Johnsen S, et al. A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car. Clin Ther 2003;25:1518–38
   PubMed Web of Science ®Google Scholar
• Dresser GK, Schwartz UI, Wilkinson GR, Kim RB. Coordinate induction of both cytochrome P4503A and MDR1 by St John’s Wort in healthy subjects. Clin Pharmacol Ther 2003;73:41–50
   PubMed Web of Science ®Google Scholar
• Dresser GK, Bailey DG, Leake BF, Schwarz UI, et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 2002;71:11–20
   PubMed Web of Science ®Google Scholar
• Parkin C, Fairweather DB, Shamzi Z, Stanley N, et al. The effect of cigarette smoking on overnight performance. Psychopharmacology 1998;136:172–8
   PubMed Web of Science ®Google Scholar
• Wesnes K, Warburton DM. The effects of cigarettes on varying yield of information processing performance. Psychopharmacology 1984;82:338–42
   PubMed Web of Science ®Google Scholar
• Mackay M, Tiplady B, Scholey AB. Interactions between alcohol and caffeine in relation to psychomotor speed and accuracy. Hum Psychopharmacol 2002;17:151–6
   Google Scholar
• Carskadon MA, Dement WC. The multiple sleep latency test: what does it measure? Sleep 1982;5(Suppl 2):S67–S72
   PubMedGoogle Scholar
• Patat A, Paty I, Hindmarch I. Pharmacodynamic profile of Zaleplon, a new benzodiazepine hypnotic agent. Hum Psycho-pharmacol 2001;16:369–92
   Google Scholar
• Ridout F, Hindmarch I. The effects of acute doses of fexofenadine, promethazine, and placebo on cognitive and psycho-motor function in healthy Japanese volunteers. Ann Allergy Asthma Immunol 2003;90:404–10
   PubMed Web of Science ®Google Scholar
• Hindmarch I. Psychomotor function and psychoactive drugs. Br J Clin Pharmacol 1980;10:189–209
   PubMed Web of Science ®Google Scholar
• Sherwood N, Kerr JS. The reliability, validity and pharmaco-sensitivity of 4 psychometric tests. In Hindmarch I and Stonier PD, editors. Human Psychopharmacology: Measures and Methods, vol. 4. Chichester: John Wiley and Sons; 1993. p. 1–15
   Google Scholar
• Smith JM, Misiaki K. Critical flicker fusion frequency (CFF) and psychotropic drugs in normal human subjects – a review. Psychopharmacologica 1976;47:175–82
   PubMed Web of Science ®Google Scholar
• Hindmarch I, Gudgeon AC. The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability. Br J Clin Pharmacol 1980;10:145–50
   PubMed Web of Science ®Google Scholar
• Johns MW. Reliability and factor analysis of the Epworth Sleepiness scale. Sleep 1992;15:919–23
   Google Scholar
• Parrot AC, Hindmarch I. The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations. Psychopharmacology (Berl) 1980;71:173–9
   PubMed Web of Science ®Google Scholar
• Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. US Department Health, Education and Welfare, National Institute of Health Publication No.204, Washington, 1968
   Google Scholar
• Vermeeren A, O’Hanlon JF. Fexofenadine’s effects, alone and with alcohol, on actual driving and psychomotor performance. J Allergy Clin Immunol 1998;101:306–11
   PubMed Web of Science ®Google Scholar
• Johnson AD, Wang D, Sadee W. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics. Pharmacol Ther 2005;106:19–38
   Google Scholar
• Vuurman EFPM, Rikken GH, Muntjewerff ND, de Halleux F, et al. Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. Eur J Clin Pharmacol 2004;60:307–13
   Google Scholar
• Moskowitz H, Burns MB. Effects of terfenadine, diphenhydramine, and placebo on skills performance. Cutis 1988;42: 14–8
   PubMed Web of Science ®Google Scholar
• Theunissen EL, Jonkman LM, Kuypers KPC, Ramaekers JG. A combined neurophysiological and behavioural study into the stimulating effects of fexofenadine on performance. J Psychopharmacol 2005 [in press]
   Google Scholar
• Bower EA, Moore JL, Moss M, Selby KA, et al. The effects of single-dose fexofenadine, diphenhydramine, and placebo on cognitive performance in flight personnel. Aviat Space Environ Med 2003;74:145–52
   PubMed Web of Science ®Google Scholar
• Kay GG, Plotkin KE, Quig MB, Starbuck VN, et al. Sedating effects of AM/PM antihistamine dosing with evening chlorpheniramine and morning terfenadine. Am J Managed Care 1997;3:1843–8
   Web of Science ®Google Scholar
• Tagawa M, Kano M, Okamura N, Higuchi M, et al. Differential cognitive effects of ebastine and chlorpheniramine in healthy subjects: correlation between cognitive impairment and plasma drug concentration. Br J Clin Pharmacol 2002;53:296–304
   PubMed Web of Science ®Google Scholar
• Nicholson AN, Pascoe PA. Rapid eye movement sleep and sleep continuity. Drugs 1989;38:4–13
   PubMed Web of Science ®Google Scholar
• Nicholson AN, Pascoe PA, Stone BM. Histaminergic systems and sleep: studies in man with H1 and H2 antagonists. Neuro-pharmacology 1985;24: 245–50
   Google Scholar
• Benington JH, Heller HC. Monoaminergic and cholinergic modulation of REM-sleep timing in rats. Brain Res 1995; 681:141–6
   PubMed Web of Science ®Google Scholar